Genscript Biotech Corp - Class H

NEW
STU:G51 (USA)   Class H
€ 2.7 +0.020 (+0.75%) Aug 12
At Loss
P/B:
1.84
Market Cap:
€ 6.00B ($ 6.91B)
Enterprise V:
€ 5.52B ($ 6.36B)
Volume:
2.00K
Avg Vol (2M):
3.35K
Trade In:

Genscript Biotech Corp (STU:G51) Dividend

Genscript Biotech Corp (STU:G51) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -1.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:G51 Dividend

Does Genscript Biotech Corp (STU:G51) pay a dividend?

Genscript Biotech Corp (STU:G51) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Genscript Biotech Corp pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Genscript Biotech Corp has returned capital to shareholders via buybacks at a rate of -1.1% over the past 3 years.

What are dividend-paying alternatives to Genscript Biotech Corp?

For dividend-paying alternatives in Genscript Biotech Corp's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.